Glial Cell Line-Derived Neurotrophic Factor (GDNF) Gene Delivery Protects Dopaminergic Terminals from Degeneration

This publication has 55 references indexed in Scilit:

• A commentary on glial cell line-derived neurotrophic factor (GDNF): From a glial secreted molecule to gene therapy
  Biochemical Pharmacology, 1999
• Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice
  Neuroscience Letters, 1998
• Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease
  Proceedings of the National Academy of Sciences, 1997
• Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy
  Science, 1997
• Studies on Neuroprotective and Regenerative Effects of GDNF in a Partial Lesion Model of Parkinson's Disease
  Neurobiology of Disease, 1997
• Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area
  Molecular Brain Research, 1996
• Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons
  Journal of Comparative Neurology, 1995
• Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain
  Nature, 1995
• Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age.
  Proceedings of the National Academy of Sciences, 1992
• Dendritic release of dopamine in the substantia nigra
  Nature, 1981